MarketScreener Editorial Features Mabwell (Shanghai) Bioscience Co., Ltd.
Equities
688062
CNE100005RD2
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.4 CNY | -2.74% | +1.37% | +2.17% |
05-24 | Mabwell Announces 9MW2821 Clinical Data | CI |
05-13 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
- Stock Market
- Equities
- 688062 Stock
- News Mabwell (Shanghai) Bioscience Co., Ltd.
- MarketScreener Editorial Features